Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to -$226.8 million.

  • Accendra Health's Free Cash Flow fell 64729.61% to -$226.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$339.6 million, marking a year-over-year decrease of 895380.6%. This contributed to the annual value of -$49.4 million for FY2024, which is 10897.9% down from last year.
  • Accendra Health's Free Cash Flow amounted to -$226.8 million in Q3 2025, which was down 64729.61% from -$77.0 million recorded in Q2 2025.
  • Over the past 5 years, Accendra Health's Free Cash Flow peaked at $266.5 million during Q2 2023, and registered a low of -$226.8 million during Q3 2025.
  • Over the past 5 years, Accendra Health's median Free Cash Flow value was $29.2 million (recorded in 2024), while the average stood at $21.2 million.
  • Per our database at Business Quant, Accendra Health's Free Cash Flow skyrocketed by 61646.86% in 2023 and then tumbled by 64729.61% in 2025.
  • Accendra Health's Free Cash Flow (Quarter) stood at $35.8 million in 2021, then increased by 6.55% to $38.1 million in 2022, then soared by 60.89% to $61.4 million in 2023, then tumbled by 86.69% to $8.2 million in 2024, then crashed by 2876.63% to -$226.8 million in 2025.
  • Its last three reported values are -$226.8 million in Q3 2025, -$77.0 million for Q2 2025, and -$44.0 million during Q1 2025.